Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dengue Hemorrhagic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02684383
What this trial is testing

Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus Vaccine

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 14
Not applicableStudy completedNCT02833584
What this trial is testing

Safety of Paracetamol as Antipyretic in Treatment of Dengue Infection in Adults

Who this might be right for
DengueTransaminitis
Phramongkutklao College of Medicine and Hospital 123
Large-scale testing (Phase 3)Study completedNCT02979535
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease
Sanofi Pasteur, a Sanofi Company 480
Early research (Phase 1)Study completedNCT02450838
What this trial is testing

Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)UnknownNCT00966628
What this trial is testing

Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)

Who this might be right for
Dengue Shock Syndrome
Innogene Kalbiotech Pte. Ltd 50
Early research (Phase 1)Study completedNCT01782300
What this trial is testing

Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableStudy completedNCT07432061
What this trial is testing

Prediction of Infectious Diseases in LMICs Using Electronic Health Record Data

Who this might be right for
Dengue FeverElectronic Health RecordsPrediction
Mahidol University 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05229354
What this trial is testing

Dengue Controlled Human Infection Model in Dhaka, Bangladesh

Who this might be right for
Dengue
Beth Kirkpatrick 192
Not applicableStudy completedNCT03206541
What this trial is testing

Neurologic Manifestations of the Arbovirus Infection in Colombia

Who this might be right for
EncephalitisMyelitisGuillain-Barre Syndrome+5 more
Johns Hopkins University 570
Testing effectiveness (Phase 2)Study completedNCT05710224
What this trial is testing

Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002)

Who this might be right for
Dengue
Butantan Institute 1,364
Not applicableLooking for participantsNCT07040202
What this trial is testing

Immune Responses to Dengue and Sepsis

Who this might be right for
DengueSepsisInfluenza
Institut Pasteur du Cambodge 240
Not applicableStudy completedNCT06268691
What this trial is testing

Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating

Who this might be right for
DengueVector Borne DiseasesArbovirus Infections+2 more
Rocio Cardenas Sanchez 35,000
Testing effectiveness (Phase 2)Study completedNCT02741128
What this trial is testing

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Immunodeficiency Virus
Sanofi Pasteur, a Sanofi Company 133
Testing effectiveness (Phase 2)UnknownNCT00849602
What this trial is testing

The Effect of Chloroquine in the Treatment of Patients With Dengue

Who this might be right for
Dengue
University of Sao Paulo 132
Large-scale testing (Phase 3)Study completedNCT01374516
What this trial is testing

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverDengue
Sanofi Pasteur, a Sanofi Company 20,869
Large-scale testing (Phase 3)Looking for participantsNCT06665035
What this trial is testing

2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers

Who this might be right for
Dengue Fever
Takeda 212
Testing effectiveness (Phase 2)Study completedNCT00740155
What this trial is testing

Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults

Who this might be right for
Dengue VirusDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi Pasteur, a Sanofi Company 154
Not applicableStudy completedNCT01030211
What this trial is testing

Adult Dengue Platelet Study

Who this might be right for
Dengue Fever
Tan Tock Seng Hospital 372
Not applicableLooking for participantsNCT06894901
What this trial is testing

Impact of IIT-SIT on Dengue Clusters

Who this might be right for
Dengue
National Environment Agency, Singapore 900
Not applicableUnknownNCT02606019
What this trial is testing

The Use of Biomarkers in Predicting Dengue Outcome

Who this might be right for
Dengue
Universiti Tunku Abdul Rahman 108
Next Page